PubRank

S Machele Donat

Author PubWeight™ 62.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2008 5.64
2 Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009 4.27
3 A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer 2008 2.53
4 Complications after radical and partial nephrectomy as a function of age. J Urol 2010 2.36
5 Defining optimal therapy for muscle invasive bladder cancer. J Urol 2007 2.30
6 Management of low grade papillary bladder tumors. J Urol 2007 2.04
7 Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002 1.90
8 Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007 1.87
9 A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2006 1.79
10 Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2007 1.76
11 A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008 1.76
12 Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008 1.62
13 Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 2007 1.56
14 Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol 2004 1.50
15 Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. J Urol 2010 1.48
16 Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol 2010 1.47
17 Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol 2010 1.38
18 Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer Immun 2003 1.19
19 Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int 2009 1.13
20 Quality control in transurethral resection of bladder tumours. BJU Int 2008 1.08
21 Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 2003 1.03
22 Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology 2007 1.02
23 Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol 2002 1.01
24 Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. J Urol 2004 0.99
25 Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU Int 2006 0.98
26 Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer 2006 0.93
27 Natural history of positive urinary cytology after radical cystectomy. J Urol 2006 0.93
28 Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol 2007 0.92
29 Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004 0.90
30 A plea for a uniform surveillance schedule after radical cystectomy. J Urol 2011 0.90
31 Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? J Urol 2005 0.88
32 Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU Int 2013 0.88
33 Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome. AJR Am J Roentgenol 2008 0.87
34 Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. J Urol 2007 0.85
35 Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urol Oncol 2010 0.85
36 Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU Int 2014 0.85
37 Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. J Urol 2006 0.84
38 Urinary diversion practice patterns among certifying American urologists. J Urol 2012 0.84
39 Elisabeth Pauline Pickett (1918-): opening the door for women in urological oncology. J Urol 2007 0.83
40 Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. J Urol 2006 0.83
41 Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU Int 2011 0.79
42 Urinary diversion: options, patient selection, and outcomes. Semin Oncol 2007 0.79
43 Perioperative clinical thromboembolic events after radical or partial nephrectomy. Urology 2006 0.78
44 Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor. Urology 2002 0.77
45 Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362). Urology 2011 0.75
46 Editorial comment. J Urol 2010 0.75
47 Assessing urological complications of radiation therapy and surgical approaches for repair. J Urol 2010 0.75
48 Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU Int 2010 0.75
49 12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report. Urol Oncol 2012 0.75